Catalyst Wire Dossier Catalyst Wire Dossier

VELETRI

EPOPROSTENOL · Actelion Pharmaceuticals US, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for VELETRI, covering 2008-06-27 to 2020-10-21. Get the full timeline:

Most recent: FDA Approved: VELETRI — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

See pricing